Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:31:45.024Z.
Calculation as of: 2026-10-06T20:31:45.024Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 33649c4c01683a9af2a16592a0768676bab1dc5ff5bd6572e384150bc13b4d03
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$231.77M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.37M
Operating Cash Flow Yield
N/A
TTM Avg
1.61%
3Y Avg
1.61%
5Y Avg
1.61%
Market Cap
$235.08M
Operating Cash Flow Yield
5.04%
TTM Avg
6.66%
3Y Avg
7.54%
5Y Avg
7.09%
Market Cap
$235.66M
Operating Cash Flow Yield
17.63%
TTM Avg
15.21%
3Y Avg
15.21%
5Y Avg
15.21%
Market Cap
$235.97M
Operating Cash Flow Yield
N/A
TTM Avg
17.96%
3Y Avg
12.82%
5Y Avg
11.02%
Market Cap
$236.82M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $232.72M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | N/A | 1.61% | 1.61% | 1.61% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 5.04% | 6.66% | 7.54% | 7.09% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 17.63% | 15.21% | 15.21% | 15.21% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | N/A | 17.96% | 12.82% | 11.02% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | N/A | N/A | N/A | N/A |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $227.60M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
